Margaret Tawadrous

12PUBLICATIONS
17CO-AUTHORS
Medical mycologyMedical bacteriologyMedical infection agents (incl. prions)Gene and molecular therapyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 16, 2024
A phase 1 open label study to assess the human mass balance and metabolite profile of 14C-fosmanogepix, a novel Gwt-1 inhibitor in healthy male participants.

Michael R Hodges, Eric Ople, Philip Evans

|May 31, 2024
Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis.

Ryan K Shields, Juan P Horcajada, Shweta Kamat

|May 17, 2024
Phase 1 drug-drug interaction study to assess the effect of CYP3A4 inhibition and pan-CYP induction on the pharmacokinetics and safety of fosmanogepix in healthy participants.

Michael R Hodges, Sjoerd van Marle, William G Kramer

|Mar 29, 2024
Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants.

Michael R Hodges, Susan Hazel, William G Kramer

|Sep 13, 2023
Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programme.

Antoni Torres, Michele Wible, Margaret Tawadrous

|Sep 08, 2023
Phase 1b safety and pharmacokinetics of intravenous and oral fosmanogepix in patients with acute myeloid leukaemia and neutropenia.

Oliver A Cornely, Helmut Ostermann, Philipp Koehler

Pageof 2

Frequent Collaborators

3 joint publications

Abhijeet Jakate

2 joint publications

Shweta Kamat

2 joint publications

Tobias Welte

2 joint publications

Juan P Horcajada